An anti-cancer drug extracted from cow urine and developed by an affiliate of the RSS has got a third US patent for its anti-genotoxicity properties.
The same extract, developed by RSS backed Go Vigyan Anusandhan Kendra, had earlier got the US patent as a bio- enhancer with antibiotics and anti-cancer drugs.
Research for the drug, whose brand name is 'Kamdhenu Ark', was carried out jointly by the Kendra and National Environmental Engineer Research Institute (NEERI), Tapan Chakraborty, Acting Director of NEERI, said while giving details about the patent received recently.
The research found that Re-distilled Cow Urine Distillate (RCUD) was useful for protecting and repairing DNA from oxidative damage, Chakraborty and Sunil Mansinghka of Kendra told reporters here on Wednesday.
Oxidative DNA damage is a leading cause of ageing, cancer and other diseases.
RCUD works against genotoxicity, a harmful action on a cell's genetic material, they said, adding research has strengthened the efficacy of kamdhenu ark as anti-cancer drug.
The research was carried out on three patients, two of them having throat and uterus cancer, Mansinghka said.
